{"DataElement":{"publicId":"3227010","version":"1","preferredName":"DNA Crosslinking Agent Use Type","preferredDefinition":"A description of the DNA cross-linking agent used.","longName":"3226983v1.0:3202961v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3226983","version":"1","preferredName":"DNA Crosslinking Agent Use","preferredDefinition":"An agent able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI)_Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"3219064v1.0:2177321v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3219064","version":"1","preferredName":"DNA Crosslinking Agent","preferredDefinition":"An agent able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI)","longName":"C25760","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Crosslinking Agent","conceptCode":"C25760","definition":"An agent able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FD029ED-603E-D143-E040-BB89AD434DB5","latestVersionIndicator":"Yes","beginDate":"2011-03-31","endDate":null,"createdBy":"BLKLDR","dateCreated":"2011-03-31","modifiedBy":"ONEDATA","dateModified":"2011-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177321","version":"1","preferredName":"Use","preferredDefinition":"Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"Use","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-52CF-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0A83216-C102-8831-E040-BB89AD4349A1","latestVersionIndicator":"Yes","beginDate":"2011-04-11","endDate":null,"createdBy":"BLKLDR","dateCreated":"2011-04-11","modifiedBy":"KUMMEROA","dateModified":"2021-03-31","changeDescription":". 2021-3-31 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3202961","version":"1","preferredName":"DNA Crosslinking Agent Use Type","preferredDefinition":"Agents able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI)_A manner, or usual, or accepted practice of using something._Type; a subdivision of a particular kind of thing.","longName":"3202961v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other agent","valueDescription":"Other Agent","ValueMeaning":{"publicId":"3202962","version":"1","preferredName":"Other Agent","longName":"3202962","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AEBB-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"MAESKEB","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E727F7D-AED3-154D-E040-BB89AD4315DA","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"Mitomycin C","valueDescription":"Mitomycin C","ValueMeaning":{"publicId":"3202964","version":"1","preferredName":"Mitomycin C","longName":"3202964","preferredDefinition":"A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species.  Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis.  Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitomycin","conceptCode":"C1820","definition":"A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species.  Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis.  Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AEE0-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E727F7D-AEF9-154D-E040-BB89AD4315DA","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"},{"value":"Diepoxybutane","valueDescription":"Diepoxybutane","ValueMeaning":{"publicId":"3202966","version":"1","preferredName":"Diepoxybutane","longName":"3202966","preferredDefinition":"A colorless, highly flammable, liquid cyclic ether. Diepoxybutane is primarily used for research purposes, but is also used as a curing agent for polymer resins and as a cross-linking agent for making synthetic textile fibers. Exposure to this substance can severely irritate and burn the eyes and skin and can cause liver damage. Diepoxybutane is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diepoxybutane","conceptCode":"C44373","definition":"A colorless, highly flammable, liquid cyclic ether. Diepoxybutane is primarily used for research purposes, but is also used as a curing agent for polymer resins and as a cross-linking agent for making synthetic textile fibers. Exposure to this substance can severely irritate and burn the eyes and skin and can cause liver damage. Diepoxybutane is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AF06-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E727F7D-AF1F-154D-E040-BB89AD4315DA","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3202960","version":"1","preferredName":"DNA Crosslinking Agent Use Type","preferredDefinition":"Agents able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI):Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.:Type; a subdivision of a particular kind of thing.","longName":"C25760:C25340:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Crosslinking Agent","conceptCode":"C25760","definition":"An agent able to covalently bind to DNA causing inter- or intra-stranded cross-linking of DNA.  The cross-linking results in misreading of the DNA code and inhibition of DNA synthesis. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AE94-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E727F7D-AEA5-154D-E040-BB89AD4315DA","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-14","modifiedBy":"KUMMEROA","dateModified":"2021-03-31","changeDescription":". 2021-3-31 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964895","version":"1","longName":"2029r1: Fanconi Anemia / Constitutional Anemia Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"fan_base_dnr_tst_cell_agt","type":"NMDP_FN","context":"NHLBI"},{"name":"fan_base_rec_tst_cell_agt","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the type of cross-lin","type":"Preferred Question Text","description":"Specify the type of cross-linking agent used:","url":null,"context":"NHLBI"},{"name":"Specify the type of cross-linking agent used","type":"Alternate Question Text","description":"Specify the type of cross-linking agent used","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0A83714-D4B3-63CF-E040-BB89AD435B97","latestVersionIndicator":"Yes","beginDate":"2011-04-11","endDate":null,"createdBy":"BLKLDR","dateCreated":"2011-04-11","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeDescription":". 2021-3-31 ak OK to release per WZ. 2021-3-5 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}